The analyses were performed blinded to the mutation profile of the patient material and distinct DS-ALL patient profiles for RAS-activity and TSLP-inducibility of RAS were observed in WB (Fig. 4a) and confirmed by ELISA (Fig. 4b). Here, TSLP is linked to acute lymphoblastic leukemia.